A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Recruiting now · Phase 1/Phase 2

Conditions studied: Breast Cancer

In brief

The purpose of this study is to find out whether pre-operative mpMRI using additional MRI sequences may improve surgical outcomes by providing more accurate information about the extent and acidity of the tumor than standard MRI, and to see whether the use of the fluorescent imaging agent pHLIP ICG and NIRF imaging during surgery is a safe approach that may allow the surgeon to see the tumor and nearby tissues that contain cancer cells more clearly and remove them completely. During the Phase IIa part of this study, the safe dose of pHLIP ICG will be used that makes it easy for the surgeon to see the tumor and the nearby tissues and structures that may contain cancer cells. This study is the first to test pHLIP ICG in people, and the first to test the use of pHLIP ICG with mpMRI and NIRF imaging in surgery for breast cancer.

Key facts

Study ID

NCT05130801

Run by

Memorial Sloan Kettering Cancer Center

People needed

55

Starts

2021-11-19

Expected to finish

2027-11-01

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or greater
• Biopsy proven primary breast malignancy (BI-RADS 6)
• Tumor stage Tis, T1 and T2, lesion size > 1 cm
• Primary surgical treatment with breast conservation
• No previous treatment
• ECOG performance of 0-2

You may not qualify if…

• Life expectancy < 3 months
• Pregnancy or lactation
• Known metastatic liver disease, hepatic neoplasms (benign and malignant), biliary atresia, chronic liver disease (CLD) and cirrhosis.
• Known moderate hepatic impairment (in phase I, and in phase IIa dependent on safety profile established in phase I)
• Known hypersensitivity to indocyanine green.
• Individuals with impaired-decision making capacity

Where it is running

• Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States (enrolling)
• Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.